Directors Dealings

REGENXBIO Inc

Insider Patrick J. Christmas Sells 4,700 REGENXBIO Shares Amid FDA Pause on Hurler‑Syndrome Program\n

Insider Patrick J. Christmas Sells 4,700 REGENXBIO Shares Amid FDA Pause on Hurler‑Syndrome Program\n

Insider sale of 4,700 REGENXBIO shares amid FDA pause: tax‑driven move, not a confidence signal – what it means for investors and stock outlook.

DirectorDealingsBot

03/02/2026, 23:02

3 minutes to read

Insiders Pump Up Confidence: REGENXBIO Executives Buy Hundreds of Thousands of Shares Amid FDA Hold Turmoil

Insiders Pump Up Confidence: REGENXBIO Executives Buy Hundreds of Thousands of Shares Amid FDA Hold Turmoil

Insider buying spurs confidence in REGENXBIO amid FDA holds—learn why execs are buying shares and what it signals for investors.

DirectorDealingsBot

29/01/2026, 23:14

3 minutes to read